Cancer Chemotherapy 1990

This Annual series provides clinicians with a systematic yearly update of current information on the clinical and experimental pharmacology of chemotherapeutic agents in the treatment of cancer. Over the past few years, the Annual series has reflected the increasing contribution of biological response modifiers to the treatment and understanding of cancer. This, the eleventh annual, covers the latest advances in this area. In addition, the development of new cytokines is covered, and the new antiretroviral drugs being developed for the treatment of AIDS included. Supportive care is highlighted, with particular reference to the remarkable results emerging from testing the value of best supportive care compared to anti-cancer treatment in various tumortypes. Advances in anti-emetic treatment are also anticipated.
 
This Annual series provides clinicians with a systematic yearly update of current information on the clinical and experimental pharmacology of chemotherapeutic agents in the treatment of cancer. Over the past few years, the Annual series has reflected the increasing contribution of biological response modifiers to the treatment and understanding of cancer. This, the eleventh annual, covers the latest advances in this area. In addition, the development of new cytokines is covered, and the new antiretroviral drugs being developed for the treatment of AIDS included. Supportive care is highlighted, with particular reference to the remarkable results emerging from testing the value of best supportive care compared to anti-cancer treatment in various tumortypes. Advances in anti-emetic treatment are also anticipated.